Senior Scientist, Analytical Development

enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene's PROPRIETARY, Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit Role enGene Inc. is seeking curious, passionate, and motivated Senior Scientist who will play a key role in the analytical group. In collaboration with others in the team, you will be an integral part of developing an exciting new gene therapy technology. You will be responsible for overseeing the analytical aspects...